UT-Southwestern Medical Center: Warfarin Use Should Not Disqualify Stroke Patients From Lifesaving Clot-Removing Surgery
June 27, 2023
June 27, 2023
DALLAS, Texas, June 27 (TNSjou) -- The University of Texas Southwestern Medical Center issued the following news release:
* * *
Risk of brain bleed negligible for most patients on common anti-clotting drug, UT Southwestern study finds
* * *
Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Med . . .
* * *
Risk of brain bleed negligible for most patients on common anti-clotting drug, UT Southwestern study finds
* * *
Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Med . . .